KZIA

MKT CAP:$144M

Kazia Therapeutics Ltd ADR

Market Cap

$144M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$10.99+$5.99 (+119.80%)

Jun 5, 2026

52W High $15.7252W Low $5.00

Company Details

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoin...

CEO

—

IPO Date

Jan 6, 1999

Website

www.kaziatherapeutics.com

Key Metrics TTM (AUD)

Revenue

AUD 3M

+196548.1% YoY

Net Income

-AUD 51M

EPS (Diluted)

Free Cash Flow

-AUD 17M

Revenue / Share

AUD 0.81

Gross Margin

100.0%

Operating Margin

-1866.7%

Net Margin

-2008.8%

FCF Margin

-655.2%

P/S

P/E

Earnings Reports

Q2 2026

Mar 30, 2026

Q1 2026

Nov 7, 2025

AUD 19.7K-99.2%

FY 2025

Nov 7, 2025

AUD 42.0K-98.2%

Q2 2025

Mar 13, 2025

AUD 22.3K+445700.0%

Q1 2025

Nov 15, 2024

AUD 2M+247999.5%

Revenue & Profitability (AUD)

Operating Cash Flow (AUD)

CapEx Spend (AUD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (AUD)

OpEx Breakdown (AUD)

War Chest (AUD)

Shares Outstanding